Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Misonix, a developer of minimally invasive ultrasonic medical device technology, has entered into an interim distribution agreement with Lithomobile, a division of Alliance Medical, based in Milano, Italy.
Subscribe to our email newsletter
Under the terms of the agreement, Lithomobile will provide the Sonablate 500 high intensity focused ultrasound (HIFU) system, on a mobile fee for service basis, to two hospitals, Ospedale Michele and Casa di Cura Arco dell’ Angelo, both located in Cagliari, Sardinia.
Misonix will supply the equipment and support services, and, in return, will receive the bulk of the revenue. Lithomobile and Misonix are in negotiations for a definitive agreement for distribution of the Sonablate throughout Italy.
The Sonablate is an HIFU instrument used for the trans-rectal ablation of tumors of the prostate gland. Characteristics of HIFU, when used for this purpose, are clinical outcomes similar to other treatment modalities, but with low instances of urinary incontinence and sexual impotence, said Misonix.
Michael McManus, Jr, president and CEO of Misonix, said: “Misonix is pleased to partner with Lithomobile to provide prostate HIFU to two important hospitals in Sardinia. Lithomobile’s experience with the mobile fee for service business segment makes Lithomobile a particularly appealing distribution partner, whose strengths blend well with Misonix’s business strategy for HIFU.”